Dual strategy testing with electrochemiluminescence and ELISA for sero-prevalence of transfusion transmitted viral infections in blood bank
Abstract
Introduction: Transfusion transmittable infections (TTI) continue to be a major threat to safe transfusion practices. Blood is one of the major sources of transmission of infectious diseases viz. human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis, malaria, and many other infections in India. Screening assays for the infectious diseases with excellent sensitivity and specificity helps to enhance the safety of the blood transfusions reducing the diagnostic window period as much as possible.
Methods: The present study was designed to determine the seroprevalence of Transfusion Transmittable Infections viz., HIV, HCV, and HBV, Syphilis, malaria among the blood donors in blood bank from January 2013-December 2013. In the present study Sera samples were screened for hepatitis B surface antigen (HBsAg), antibodies to HCV, HIV using electrochemiluminescence and to syphilis using Rapid Plasma Reagin test (RPR), and to malaria by peripheral smear respectively. All samples were screened for HIV, HBsAg, HCV, syphilis and malaria.
Results: Total 9,400 cases. Of which 51% were voluntary donors and 49% were replacement donors. The overall prevalence of HIV, HbsAg, and HCV were 0.35,1.86, and 0.22 respectively. All the markers tested there was increased prevalence of TTI among the replacement donors as compared to voluntary donors. 2.4% donors had infection of each HIV, HbsAg, and HCV. 0.21% donors had infection of both HIV and HCV.
Conclusion: The screening of blood and blood components by dual testing strategy using high sensitivity serological assay like enhanced chemiluminescence technology and NAT helps in detecting the potentially infectious blood units in all phases of infection, which aids in enhancing the safety of blood transfusion and reducing the potential risk of post-transfusion infection.
Downloads
References
2. Khan ZT, Asim S, Tariz Z, Ehsan IA, Malik RA, Ashfaq B, et al. Prevalence of Transfusion transmitted infections in healthy blood donors in Rawalpindi District, Pakistan–a five year study. Int J Pathol. 2007; 5:21–25.
3. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ. 2003; 169 (8):767-73.
4. Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana. Indian J Pathol Microbiol. 2010; 53(2): 308-9. doi: 10.4103/0377-4929.64295.
5. Pallavi P, Ganesh CK, Jayashree K, Manjunath GV. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian Journal of Hematol Blood Transfus. 2011;27(1):1-6. doi: 10.1007/s12288-010-0047-x
6. World Health Organisation. Blood safety strategy for Africal Region. Brazzaville: WHO Regional Office for Africa; 2002. World Health Organization. Status of Blood Safety in the WHO African Region: Report of the 2004 Survey. Brazzaville: WHO Regional Office for Africa; 2007. p. 1-25.
7. Tiwari BR, Ghimire P, Karki S, Rajkarnikar M. Seroprevalence of human immunodeficiency virus in Nepalese blood donors: A study from three regional blood transfusion services. Asian J Transfus Sci. 2008;2 (2):66-8. doi: 10.4103/0973-6247.42663.
8. Fiebig EW, Busch MP. Emerging infections in transfusion medicine. Clin Lab Med. 2004;24(3): 797-823. doi:10.1016/j.cll.2004.05.009
9. Gupta PK, Kumar H, Basannar DR, Jaiprakash M. Transfusion transmitted infections in armed forces: prevalence and trends. Med J Arm Force India. 2006; 62(4): 348-50. doi: 10. 1016/ S0377-1237 (06) 80105-X
10. Rao P, Annapurna K. HIV status of blood donors and patients admitted in KEM hospital, Pune. Indian J Hemat Blood Transf. 1994;12:174-6.
11. Rose D, Sudarsanam A, Pandankatti T, Babu PG, John TJ. Increasing prevalance of HIV antibody among blood donors monitored over 9 years in one blood bank. Indian J Med Res. 1998;108:42-44.
12. Singh K, Bhat S, Shastry S. Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka, India. J Infect Dev Ctries. 2009; 3(5): 376-9.
13. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. JPN J Infect Dis. 2007; 60(6):389-91.
14. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, Sack U. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010; 10(1):111. doi: 10.1186/1471-2334-10-111.
15. Gelaw B, Mengitsu Y. The prevalence of HBV, HCV and malaria parasites among blood donor in Amhara and Tigray regional states. Ethiop J Health Develop. 2008;22(1):3-7.
16. Nwankwo E, Momodu I, Umar I, Musa B, Adeleke S. Seroprevalence of major blood-borne infections among blood donors in Kano, Nigeria. Turk J Med Sci. 2012; 42(2):337-41. doi:10.3906/sag-1009-1176
17. Koram SK, Bollipogu S, Veldurthi VS. Prevalence of HIV, hepatitis B, hepatitis C and syphilis in blood donors at tertiary care centre. Int J Res Health Sci. 2014; 2(1):290-4.
18. Ali IM, Amirthalingam R. Seroprevalence of HBV, HCV and HIV infectivity among blood donors in ibn sina teaching hospital in sirt region of Libya. Int J Med Res Health Sci. 2013;2(4):816-22. doi: 10.5958/j.2319-5886.2.4.130
19. Teo KS, Saparudin MS, Zaini Z, Ahmad Morshidi M, Metassan N, Jaberudin R et al. Transfusion transmissible infections in Brunei Darussalam: a blood donor study. Brunei Int Med J. 2011;7(6):321-7.
20. Fessehaye N, Naik D, Fessehaye T. Transfusion transmitted infections–A retrospective analysis from the National Blood Transfusion Service in Eritrea. Pan Af Med J. 2011;9(1):1-6. doi: 10.4314/pamj.v9i1.71219.
21. Manzoor I, Hashmi NO, Daud SE, Ajmal SA, Fatima HI, Rasheed ZA, Syed SA. Seroprevalence of transfusion transmissible infections (TTIS) in blood donors. Biomed. 2009;25(10):154-8.
22. Saghir SAM, Hassan FMA, Alsalahi OSA, Alhariry AEAA, Baqir HS. Frequencies of HBV, HCV, HIV, and syphilis markers among blood donors: a hospital-based study in Hodeidah, Yemen. Trop J Pharm Res. 2012; 11(1):132–136. doi: 10.4314/tjpr.v11i1.
23. Abdallah TM, Ali AAA. Sero-prevalence of transfusion-transmissible infectious diseases among blood donors in Kassala, eastern Sudan. J Med Med Sci. 2012;3(4):260–262.
24. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10(1):111. doi: 10.1186/1471-2334-10-111.
OAI - Open Archives Initiative
